These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 8365653

  • 21. Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV.
    Hall KL, Hanesworth JM, Ball AE, Felgenhauer GP, Hosick HL, Harding JW.
    Regul Pept; 1993 Mar 19; 44(2):225-32. PubMed ID: 8469776
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Regulation of receptor binding interactions of 125I-angiotensin II and 125I-[sarcosine1,leucine8]angiotensin II, an angiotensin antagonist, by sodium ion.
    Bennett JP, Snyder SH.
    Eur J Pharmacol; 1980 Oct 03; 67(1):1-10. PubMed ID: 6252018
    [Abstract] [Full Text] [Related]

  • 25. Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis.
    Cao Z, Kelly DJ, Cox A, Casley D, Forbes JM, Martinello P, Dean R, Gilbert RE, Cooper ME.
    Kidney Int; 2000 Dec 03; 58(6):2437-51. PubMed ID: 11115077
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The relationship between homotropic and heterotropic cooperativity for angiotensin receptors in smooth muscle.
    Scanlon MN, Koziarz P, Moore GJ.
    Gen Pharmacol; 1990 Dec 03; 21(1):59-65. PubMed ID: 2105260
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Sar1-p-benzoylphenylalanine-angiotensin, a new photoaffinity probe for selective labeling of the type 2 angiotensin receptor.
    Bossé R, Servant G, Zhou LM, Boulay G, Guillemette G, Escher E.
    Regul Pept; 1993 Mar 19; 44(2):215-23. PubMed ID: 8469775
    [Abstract] [Full Text] [Related]

  • 32. Binding characteristics and vascular effects of various angiotensin II antagonists.
    Criscione L, Thomann H, Whitebread S, de Gasparo M, Bühlmayer P, Herold P, Ostermayer F, Kamber B.
    J Cardiovasc Pharmacol; 1990 Mar 19; 16 Suppl 4():S56-9. PubMed ID: 1705629
    [Abstract] [Full Text] [Related]

  • 33. Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist.
    Krebs LT, Kramár EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW.
    Regul Pept; 1996 Dec 03; 67(2):123-30. PubMed ID: 8958583
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Importance of the N-terminal domain of the type I angiotension II antagonist [Sar1,Ile8]ANG II for receptor blockade.
    Moore GJ, Ganter RC, Goghari MH, Franklin KJ.
    Int J Pept Protein Res; 1991 Jul 03; 38(1):1-7. PubMed ID: 1938100
    [Abstract] [Full Text] [Related]

  • 37. Angiotensin II receptor subtypes in renal cortex of rats and rhesus monkeys.
    Gibson RE, Thorpe HH, Cartwright ME, Frank JD, Schorn TW, Bunting PB, Siegl PK.
    Am J Physiol; 1991 Sep 03; 261(3 Pt 2):F512-8. PubMed ID: 1653532
    [Abstract] [Full Text] [Related]

  • 38. Effect of uncoupling agents on AT1 receptor affinity for antagonist analogs of angiotensin II.
    Poitras M, Sidibé A, Richard DE, Chrétien L, Guillemette G.
    Recept Channels; 1998 Sep 03; 6(1):65-72. PubMed ID: 9664623
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.